Stocks Health care BIOE
OTC · Health careBio Essence Corp (BIOE)
Bio Essence Corp brought in $2.9M of revenue over the twelve months to June 30, 2026. Net income was $1.5M, a net margin of 52.1%. At June 30, 2026 it held $675 in cash against $56.8K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch BIOE in 60 secondsWhat Bio Essence Corp does
Bio Essence Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BIOE.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.9M | $896.2K | n/a | n/a |
| 2024 | $323.9K | -$1.3M | -$0.03 | n/a |
| 2023 | $551.5K | -$971.9K | -$0.03 | -$1M |
| 2022 | $621.6K | -$809.7K | -$0.03 | -$707K |
| 2021 | $888K | -$647.6K | -$0.03 | -$1.4M |
| 2021 | $958.7K | -$595.8K | -$0.03 | -$740.1K |
Full financial statements: income, balance sheet and cash flow
Where BIOE ranks in Health care
Latest SEC filings
What Bio Essence Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 207% to $794.7K versus the same quarter last year; net income rose 351% to $270.1K.
- May 19, 2026Material agreement 8-K/A
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 2,156% to $500.5K versus the same quarter last year; net income of $205.4K versus a net loss of $205.8K.
- April 24, 2026
- March 27, 2026Annual report 10-K · period to December 31, 2025Revenue rose 486% to $1.9M versus the prior year; net income of $896.2K versus a net loss of $1.3M.
- January 5, 2026Form QUALIF filing QUALIF
- November 12, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 1.6% to $136.8K versus the same quarter last year; net income of $13K versus a net loss of $1.2M.
- October 17, 2025Form 1-A filing 1-A
- August 14, 2025
- May 15, 2025
Questions about BIOE
What does Bio Essence Corp do?
Bio Essence Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker BIOE.
Is Bio Essence Corp profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $1.5M on revenue of $2.9M, a net margin of 52.1%.
How much revenue does Bio Essence Corp make?
Over the twelve months to June 30, 2026 Bio Essence Corp reported revenue of $2.9M.
When did Bio Essence Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare BIOE with
Follow BIOE
Get an email when Bio Essence Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow BIOE: get an email when it filesWhere the numbers come from
Financial figures are the values Bio Essence Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.